Obesity linked to heavy periods and impaired womb repair: Study

In this study, Dr Jacqueline Maybin and colleagues at the MRC Centre for Reproductive Health at the University of Edinburgh, examined how body mass index (BMI) may affect womb function during menstruation in women, and also in female mice. The researchers measured the BMI and menstrual blood loss of 121 women, with regular menstrual cycles, who were attending gynaecology clinics and not taking any hormone medications. A weak but statistically significant association between increasing BMI and more menstrual blood loss was found. Since many other factors in women may also affect menstrual blood loss, the investigation was extended to a mouse study, where conflicting variables could be limited.

Mice were fed a normal diet or a high-fat diet prior to simulation of menstruation. Mice on high-fat diet had significantly higher body weight than those on a normal diet. After shedding their womb lining, the mice on a high-fat diet showed delayed repair of the remaining womb lining in comparison to mice on a normal diet. Further examination of womb tissue from the mice indicated that inflammatory factors were also higher in mice with greater body weight.

Dr Maybin comments, "Our findings suggest that women with obesity may experience heavier periods due to increased local inflammation and delayed repair of their womb lining. It would be really interesting to investigate the reasons behind this to further our understanding of womb function in the presence of obesity and develop more effective, evidence-based treatments."

These findings suggest that weight loss and anti-inflammatory medications may be useful interventions for treatment of heavy periods in women with obesity. However, this research was carried out on a small number of women with regular periods, who were attending gynaecology clinics and may not be representative of the general population. Additional, larger studies are needed to confirm these findings.

Dr Maybin cautions, "Although it is difficult to make strong recommendations based on this study alone, a common-sense approach would be to offer weight-loss support to women with a high BMI experiencing heavy periods. However, this should not replace investigation and treatment of other underlying causes for heavy bleeding (e.g. fibroids, bleeding disorders, cancer). This should form part of personalised treatment recommendations to be considered by both patients and doctors."